Skip to main content

Month: June 2025

OTC Markets Group Welcomes Digital Brands Group, Inc. to OTCQX

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Digital Brands Group, Inc. (OTCQX: DBGI), a company specializing in eCommerce, fashion, and luxury lifestyle brands, has qualified to trade on the OTCQX® Best Market. Digital Brands Group, Inc. upgraded to OTCQX from the Pink® market. Digital Brands Group, Inc. begins trading today on OTCQX under the symbol “DBGI.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them...

Continue reading

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa™ Fentanyl, an abuse-deterrent fentanyl patch Nutriband is partnering with Kindeva to develop Aversa™ Fentanyl which combines Nutriband’s Aversa™ abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch ORLANDO, Fla., June 18, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has completed commercial manufacturing process scale-up for its lead product, Aversa™ Fentanyl, with Kindeva, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products. Nutriband is partnering with Kindeva to develop Aversa™...

Continue reading

NexGold VP Sustainability Receives Prestigious Mining Society of Nova Scotia Medal

TORONTO, June 18, 2025 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that Deidre Puddister, VP Sustainability with NexGold, has been honoured with the prestigious Mining Society of Nova Scotia Medal. The Mining Society Medal is awarded in recognition of exceptional service rendered to the mining industry in the Province of Nova Scotia and is decided by a special committee. The Mining Society of Nova Scotia is an independent society affiliated with the Canadian Institute of Mining, Metallurgy and Petroleum (CIM) with a rich history dating back to the 1890s in Nova Scotia. The award was announced and presented at the Mining Society’s 138th annual meeting and conference held at Oak Island Resort, Nova Scotia on June 12, 2025, which was attended by members...

Continue reading

YY Group Holding Limited Acquires Majority Stake in Transocean Oil Pte. Ltd.

Singapore, June 18, 2025 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”), a global leader in on-demand workforce solutions and integrated facility management (IFM), has acquired a 53% stake in Transocean Oil Pte. Ltd.’s property investment division, specializing in premium commercial office units in Singapore. This marks YY Group’s entry into the property investment sector, expanding its portfolio, diversifying revenue streams, and establishing a foothold in Singapore’s dynamic real estate market. Strategic Significance The acquisition supports YY Group’s growth strategy, taking advantage of Singapore’s booming real estate market, projected to grow at 6.5% annually from 2025 to 2030. “Adding premium properties to our portfolio boosts investor confidence and strengthens our...

Continue reading

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors

WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced the appointment of Rita Jain, M.D. to its Board of Directors. “We are pleased to welcome Dr. Jain to Avalo’s Board of Directors,” said Michael Heffernan, Chairman of the Board. “Rita’s extensive experience spanning clinical development, regulatory strategy, and executive leadership at multiple development-stage biopharma companies will be invaluable as we continue to advance AVTX-009, a high affinity anti-IL-1β monoclonal antibody in a Phase 2 trial for hidradenitis suppurativa (HS) and take a thoughtful, capital-efficient approach to our broader development strategy.” “I am excited to join Avalo’s Board at this pivotal stage in the company’s...

Continue reading

Gogo successfully completes first 5G end-to-end call.

5G end-to-end connection marks a significant step towards delivery of next-generation air-to-ground connectivity.Gogo ATG towerOne of 170 Gogo ATG towersBroomfield, CO., June 18, 2025 (GLOBE NEWSWIRE) — Broomfield, CO./ June 18, 2025 – Gogo (NASDAQ: GOGO) confirms today that GCT Semiconductor has successfully completed the very first end-to-end call using its next-generation 5G technology. The call, which took place on June 16, 2025, confirms the Gogo 5G chip is fully functional and ready to move through the final phases of integration. The technology milestone represents a critical stage in Gogo’s journey towards delivering 5G air-to-ground (ATG) connectivity to North American operators. GCT Semiconductor Holding, Inc. (NYSE: GCTS) delivered the new 5G chipset to Airspan, a provider of network deployment solutions and...

Continue reading

Extensive Greenland Lithium Exploration Campaign Launched by Brunswick Exploration

MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; “BRW” or the “Company”) is pleased to announce it has launched an aggressive regional-scale prospecting and mapping initiative on its sizeable Greenland portfolio that contains hundreds of untested targets using 4 crews and 2 helicopters for six weeks. Initially, one team will focus on detailed mapping and sampling around the Ivisaartoq spodumene discovery and surrounding areas while the other will focus on the expanded Nuuk and Paamiut licenses as well as the historical spodumene showing at Paamiut. Starting in July, one team will focus on follow-up prospecting at the Nuuk and Paamiut projects based on results from June while the other team will focus on the Disko Bay and Uummannaq projects. Results from the first six...

Continue reading

Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

Dr. Charles, Accomplished Immunology-Focused Drug Developer, Brings More Than 20 years of Biopharma Leadership, Clinical Development, and Operations Expertise Company Also Hires Cindy J. Driscoll, MBA, Financial Executive with Over Two Decades of Experience Guiding Biotechnology Companies, as Senior Vice President, Finance WELLESLEY HILLS, Mass., June 18, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced the appointments of Edgar D. Charles, M.D., MSc as its Chief Medical Officer (CMO) and Cindy J. Driscoll, MBA as Senior Vice President, Finance. “The expansion of our leadership team comes at a pivotal time for Climb Bio. Dr. Charles is a highly respected physician-scientist with deep expertise in immunology...

Continue reading

Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS)

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that data from across the SYMBRAVO® (meloxicam and rizatriptan) clinical program will be presented at the 67th Annual Scientific Meeting of the American Headache Society (AHS), being held June 19-22, 2025, in Minneapolis, Minnesota. Details for the presentations are as follows: Title: Efficacy of SYMBRAVO® (MoSEIC™ meloxicam and rizatriptan) by Baseline Migraine-Associated Disability: Post-Hoc Analysis of the INTERCEPT TrialLead Author: Stewart Tepper, MD, Clinical Professor of Neurology at the Geisel School of Medicine at Dartmouth and Vice President of the New England Institute for Neurology and HeadachePresentation...

Continue reading

Simply Good Foods to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, July 10, 2025

DENVER, June 18, 2025 (GLOBE NEWSWIRE) — The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced it will report financial results for the thirteen week period ended May 31, 2025, on Thursday, July 10, 2025, before market open. The Company will host a conference call to discuss these results with additional comments and details provided at that time. Participating on the call will be Geoff Tanner, President and Chief Executive Officer, and Chris Bealer, incoming Chief Financial Officer effective July 3, 2025. The conference call is scheduled to begin at 6:30 a.m. Mountain time (8:30 a.m. Eastern time) on Thursday, July 10, 2025. Investors interested in participating in the live call can dial 1-877-407-0792...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.